Table 3.
Effects of oral dosing of Saussurea lappa (S. lappa) and/or triamcinolone acetonide (TA) on hematologic variables of treated rats.
| Parameters | Experimental Groups | ||||
|---|---|---|---|---|---|
| Control | S. Lappa | TA | Co-Treated | Prophylactic | |
| RBCs (× 106/µL) | 6.92 ± 0.12 d | 6.84 ± 0.21 d | 10.77 ± 0.20 a | 8.69 ± 0.26 b | 7.66 ± 0.39 cd |
| Hb (gm %) | 14.47 ± 0.67 d | 14.83 ± 0.36 d | 21.40 ± 0.46 a | 17.93 ± 0.35 b | 16.35 ± 0.26 c |
| PCV (%) | 43.58 ± 0.98 d | 44.17 ± 0.52 d | 64.60 ± 1.18 a | 56.24 ± 1.19 b | 49.00 ± 1.10 c |
| TLC (103/µL) | 10.87 ± 0.15 d | 15.68 ± 0.64 a | 16.34 ± 0.45 a | 14.24 ± 0.20 b | 12.78 ± 0.21 c |
| Neutrophil (103/µL) | 2.14 ± 0.05 d | 2.25 ± 0.10 d | 10.38 ± 0.28 a | 7.86 ± 0.16 b | 5.37 ± 0.25 c |
| Lymphocyte (103/µL) | 8.30 ± 0.18 b | 13.00 ± 0.56 a | 5.69 ± 0.28 d | 6.05 ± 0.10 cd | 7.02 ± 0.06 c |
| Monocyte (103/µL) | 0.24 ± 0.01 ab | 0.25 ± 0.02 a | 0.14 ± 0.01 d | 0.18 ± 0.01 c | 0.21 ± 0.01 b |
| Eosinophil (103/µL) | 0.17 ± 0.01 ab | 0.18 ± 0.01 a | 0.11 ± 0.01 d | 0.13 ± 0.01 c | 0.15 ± 0.00 b |
| Basophil (103/µL) | 0.02 ± 0.001 a | 0.02 ± 0.003 a | 0.01 ± 0.001 c | 0.01 ± 0.001 bc | 0.02 ± 0.001 ab |
The data are expressed as the mean ± SE. Means within the same row carrying different superscripts (a, b, and c) are significantly different (one-way ANOVA followed by Duncan’s multiple range test, p < 0.05).